Navigation Links
Golub Capital Provides Debt Financing to Support the Acquisition of Network Express, Inc., by Ace Expediters, Inc.
Date:3/30/2009

NEW YORK, March 30 /PRNewswire/ -- Golub Capital today announced that it has provided a $27.5 million senior credit facility and equity to support the acquisition of Network Express, Inc., by Ace Expediters, Inc., a portfolio company of Atlantic Street Capital.

The combination of Ace Expediters, Inc., (which includes Ace Expediters and Express Courier, d/b/a Medifleet) and Network Express, Inc., creates the leading dedicated route logistics provider in the Eastern United States. The company provides time-critical, reliable delivery solutions for its clients that include companies in the retail auto aftermarket, long-term care pharmaceutical and medical testing laboratory end markets.

At Network Express, medical distribution services have expanded over the years to include some of the most sensitive medical deliveries such as delivering to nursing facilities, pharmaceutical wholesalers, and medical laboratories requiring specimen retrieval. In 2003, Network Express was inducted into the prestigious Inc. 500, by Inc. Magazine, as one of the fastest growing privately held companies in America.

"We are very pleased to support Atlantic Capital on growing Ace Expediters' already thriving platform. Ace's business model and financial performance is on point for what we are seeking today," says Golub Capital Senior Managing Director Andy Steuerman. "However, it is still a very challenging time to get a transaction across the finish line. This transaction utilized our knowledge of the logistics industry to complete this deal in a timely manner."

This is Golub Capital's first deal with Atlantic Street Capital.

"We felt comfortable with Golub Capital because they really understood the sector and provided a full solution in a market where very few parties are lending. After working with the Golub team on closing this deal, we are confident that Golub Capital will help us grow the company as we capitalize on opportunities within the logistics industry," says Peter Shabecoff, a partner with Atlantic Street Partners.

Atlantic Street Capital Description:

Atlantic Street Capital Management, headquartered in Stamford, CT, is a special situations private equity fund investing in middle market companies that present challenges to typical investors.

About Golub Capital

Golub Capital provides buy-and-hold products range from $5 million to $75 million and include one-loan financings (through the Firm's proprietary GOLD facility), senior, second lien and subordinated debt, preferred stock and co-investment equity. Golub Capital also underwrites and syndicates 1st lien loans up to $150 million. With a broad investment mandate and long-term time horizon, Golub Capital has a high level of flexibility in structuring investments. For more information, please visit www.golubcapital.com.


'/>"/>
SOURCE Golub Capital
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Golub Capital Provides $29.5 Million GOLD Facility in Support of the Recapitalization of ExtruMed
2. ReGear Life Sciences Closes $2.5 Million in Series A Financing Following $1M Investment by Stonewood Capital Management, Inc.
3. Capital BlueCross Reaches Out to Families of Uninsured Children
4. BioRelix and Dalton Medicinal Chemistry Expand and Renew Research Agreement to Capitalize on Riboswitches
5. Elekta Finds New Interest in Leasing Solutions as Hospitals Debate Capital Purchases
6. NASDAQ Panel Grants Extension to DATATRAK for Continued Listing on the NASDAQ Capital Market
7. Abaxis, Inc. to Attend Lazard Capital Markets Medical Technologies Conference
8. Wyclef Jean and Miri Ben-Ari to Lead Phoenix House Tribute to Lisa Ellis of Fireman Capital Partners and Carnival House Recordings
9. InstaMed Announces Osage Partners and Ashby Point Capital Have Joined Existing Investors in $6 Million Growth Equity Financing
10. LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nations Capital
11. Amgen to Present at the Barclays Capital Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... PurhealthRX , a leading ... Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil will revolutionize the rapidly ... CBD form that can be easily incorporated into liquid products, while reducing costs to ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Many families ... However, many long-term care insurance companies have a waiver for care if the client ... elimination period, when the family pays for care, is often waived, so the benefits ...
(Date:10/13/2017)... ... October 13, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House ... most popular and least understood books in the Holy Scriptures, Revelation. The Book of ... baffled scholars for centuries. Many have tossed it off as mere rubbish, but Yisrayl ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... 2017 , ... The company has developed a suite of ... authorities worldwide. From Children’s to Adults 50+, every formula has been developed by ... , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, Non-Dairy*, Preservative ...
Breaking Medicine News(10 mins):
(Date:10/12/2017)... , Oct. 12, 2017 AVACEN Medical ... the company with their  2017 New Product Innovation Award ... on extensive primary and secondary medical device market research by ... through its first-to-market OTC, drug-free pain relief product, the AVACEN ... approach to treating fibromyalgia widespread pain. ...
(Date:10/11/2017)...  Caris Life Sciences ® , a leading innovator ... precision medicine, today announced that St. Jude Medical Center,s ... (POA) as its 17 th member. Through participation ... Cancer Institute will help develop standards of care and ... making cancer treatment more precise and effective. ...
(Date:10/10/2017)...   West Pharmaceutical Services, Inc. (NYSE: WST), ... administration, today shared the results of a study highlighting ... intradermal administration of polio vaccines. The study results were ... 2017 by Dr. Ondrej Mach , Clinical Trials ... (WHO), and recently published in the journal Vaccine. ...
Breaking Medicine Technology: